Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. The January J.P. Morgan Healthcare Conf
In Vitro Diagnostics Acquisitions /In Vitro Diagnostics Abbott Laboratories Inc. Celera Corp. In a four-year deal, Celera Corp. has licensed Abbott Laboratories Inc. exclusive rights to distri
In Vitro Diagnostics Innovative Biosensors Inc. Innovative Biosensors closes $6.25mm Series A round Oct. — Innovative Biosensors (pathogen detection technologies) closed its two-tranche Series A fin